Multiple models of human metabolism have been reconstructed, but each represents only a subset of our knowledge. Here we describe Recon 2, a community-driven, consensus ‘metabolic reconstruction’, which is the most comprehensive representation of human metabolism that is applicable to computational modeling. Compared with its predecessors, the reconstruction has improved topological and functional features, including ~2× more reactions and ~1.7× more unique metabolites. Using Recon 2 we predicted changes in metabolite biomarkers for 49 inborn errors of metabolism with 77% accuracy when compared to experimental data. Mapping metabolomic data and drug information onto Recon 2 demonstrates its potential for integrating and analyzing diverse data types. Using protein expression data, we automatically generated a compendium of 65 cell type–specific models, providing a basis for manual curation or investigation of cell-specific metabolic properties. Recon 2 will facilitate many future biomedical studies and is freely available at http://humanmetabolism.org/.
Both LPC and CSU can be accessed through the PDB and are integrated in the 3DB Atlas page of all PDB files. For any given file, the tools can also be accessed at http://www.pdb.bnl. gov/pdb-bin/lpc?PDB_ID= and http://www.pdb.bnl. gov/pdb-bin/csu?PDB_ID= with the four-letter PDB code added at the end in each case. Finally, LPC and CSU can be accessed at: http://sgedg.weizmann.ac.il/lpc and http://sgedg.weizmann.ac.il/csu.
735hardly imagine today's electronics industry, with its powerful, visually oriented design and automation tools, without having first established standard notations for circuit diagrams. Such was not the case in biology 2 . Despite the visual nature of much of the information exchange, the field was permeated with ad hoc graphical notations having little in common between different researchers, publications, textbooks and software tools. No standard visual language existed for describing biochemical interaction networks, inter-and intracellular signaling gene regulation-concepts at the core of much of today's research in molecular, systems and synthetic biology. The closest to a standard is the notation long used in many metabolic and signaling pathway maps, but in reality, even that lacks uniformity between sources and suffers from undesirable ambiguities (Fig. 1). Moreover, the existing tentative representations, however well crafted, were ambiguous, and only suitable for specific needs, such as representing metabolic networks or signaling pathways or gene regulation.The molecular biology era, and more recently the rise of genomics and other high-throughput technologies, have brought a staggering increase in data to be interpreted. It also favored the routine use of software to help formulate hypotheses, design experiments and interpret results. As a group of biochemists, modelers and computer scientists working in systems biology, we believe establishing standard graphical notations is an important step toward more efficient and accurate transmission of biological knowledge among our different communities. Toward this goal, we initiated the SBGN project in 2005, with the aim of developing and standardizing a systematic and unambiguous graphical notation for applications in molecular and systems biology. Historical antecedentsGraphical representation of biochemical and cellular processes has been used in biochemical textbooks as far back as sixty years ago 3 , reaching an apex in the wall charts hand drawn by Nicholson 4 and Michal 5 . Those graphs describe the processes that transform a set of inputs into a set of outputs, in effect being process, or state transition, diagrams. This style was emulated in the first database systems that depicted metabolic networks, including EMP 6 , EcoCyc 7 and KEGG 8 . More notations have been 'defined' by virtue of their implementation in specialized software tools such as pathway and network designers (e.g., NetBuilder 9 , Patika 10 , JDesigner 11 , CellDesigner 12 ). Those "Un bon croquis vaut mieux qu'un long discours" ("A good sketch is better than a long speech"), said Napoleon Bonaparte. This claim is nowhere as true as for technical illustrations. Diagrams naturally engage innate cognitive faculties 1 that humans have possessed since before the time of our cave-drawing ancestors. Little wonder that we find ourselves turning to them in every field of endeavor. Just as with written human languages, communication involving diagrams requires that authors and readers agr...
A better understanding of human metabolism and its relationship with diseases is an important task in human systems biology studies. In this paper, we present a high-quality human metabolic network manually reconstructed by integrating genome annotation information from different databases and metabolic reaction information from literature. The network contains nearly 3000 metabolic reactions, which were reorganized into about 70 human-specific metabolic pathways according to their functional relationships. By analysis of the functional connectivity of the metabolites in the network, the bow-tie structure, which was found previously by structure analysis, is reconfirmed. Furthermore, the distribution of the disease related genes in the network suggests that the IN (substrates) subset of the bow-tie structure has more flexibility than other parts.
Resistance to targeted cancer therapies such as trastuzumab is a frequent clinical problem not solely because of insufficient expression of HER2 receptor but also because of the overriding activation states of cell signaling pathways. Systems biology approaches lend themselves to rapid in silico testing of factors, which may confer resistance to targeted therapies. In this study, we aimed to develop a new kinetic model that could be interrogated to predict resistance to receptor tyrosine kinase (RTK) inhibitor therapies and directly test predictions in vitro and in clinical samples. The new mathematical model included RTK inhibitor antibody binding, HER2/HER3 dimerization and inhibition, AKT/mitogenactivated protein kinase cross-talk, and the regulatory properties of PTEN. The model was parameterized using quantitative phosphoprotein expression data from cancer cell lines using reverse-phase protein microarrays. Quantitative PTEN protein expression was found to be the key determinant of resistance to anti-HER2 therapy in silico, which was predictive of unseen experiments in vitro using the PTEN inhibitor bp(V). When measured in cancer cell lines, PTEN expression predicts sensitivity to anti-HER2 therapy; furthermore, this quantitative measurement is more predictive of response (relative risk, 3.0; 95% confidence interval, 1.6-5.5; P < 0.0001) than other pathway components taken in isolation and when tested by multivariate analysis in a cohort of 122 breast cancers treated with trastuzumab. For the first time, a systems biology approach has successfully been used to stratify patients for personalized therapy in cancer and is further compelling evidence that PTEN, appropriately measured in the clinical setting, refines clinical decision making in patients treated with anti-HER2 therapies. [Cancer Res 2009;69(16):6713-20]
Background: In silico analyses provide valuable insight into the biology of obligately intracellular pathogens and symbionts with small genomes. There is a particular opportunity to apply systemslevel tools developed for the model bacterium Escherichia coli to study the evolution and function of symbiotic bacteria which are metabolically specialised to overproduce specific nutrients for their host and, remarkably, have a gene complement that is a subset of the E. coli genome.
Motivation: LibSBGN is a software library for reading, writing and manipulating Systems Biology Graphical Notation (SBGN) maps stored using the recently developed SBGN-ML file format. The library (available in C++ and Java) makes it easy for developers to add SBGN support to their tools, whereas the file format facilitates the exchange of maps between compatible software applications. The library also supports validation of maps, which simplifies the task of ensuring compliance with the detailed SBGN specifications. With this effort we hope to increase the adoption of SBGN in bioinformatics tools, ultimately enabling more researchers to visualize biological knowledge in a precise and unambiguous manner.Availability and implementation: Milestone 2 was released in December 2011. Source code, example files and binaries are freely available under the terms of either the LGPL v2.1+ or Apache v2.0 open source licenses from http://libsbgn.sourceforge.net.Contact: sbgn-libsbgn@lists.sourceforge.net
Li. SM and AS would also like to acknowledge Igor Goryanin whose financial support and encouragement enabled us to commit the necessary time to the development of this specification. A more comprehensive list of people involved in SBGN development is available in the appendix D. The development of SBGN was mainly supported by a grant from the Japanese New Energy and Industrial Technology Development Organization (NEDO, http://www.nedo.go.jp/).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.